Literature DB >> 26021447

Rapid and efficient purification of ficolin-2 using a disposable CELLine bioreactor.

K Aaron Geno1, Brady L Spencer2, Moon H Nahm3.   

Abstract

The human opsonin ficolin-2 (L-ficolin) is an innate pattern-recognizing molecule that binds to acetylated moieties. Upon binding, ficolin-2 activates complement through the lectin pathway, opsonizing the target to promote phagocytic clearance. Ficolin-2 has been found to interact with a growing number of pathogenic bacteria, fungi, and viruses. Ficolin-2 also has proposed roles in host homeostasis, including the clearance of apoptotic cells. Consequently, there is an increased interest in studying ficolin-2, and access to purified ficolin-2 is necessary for these studies. Ficolin-2 purified from serum, plasma, or cell culture supernatants has been a useful tool in the characterization of ficolin-2 function; however, available protocols are laborious and inefficient, requiring additional processing of starting materials (e.g., polyethylene glycol precipitation or dialysis) and multiple steps of purification. Here, we investigated a simple solution to the problem: use of a simple, disposable bioreactor requiring only standard tissue culture equipment. Using this system, we generated cell culture supernatants containing high concentrations of recombinant ficolin-2, which permitted rapid purification of high-purity recombinant ficolin-2 without processing the supernatants. Purified recombinant ficolin-2 retained its binding capacity and supported complement activation in vitro. Bioreactor cultivation will likely be generally useful in the production of other recombinant proteins in the study of the complement system.
Copyright © 2015 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Complement; Innate immunity; L-Ficolin; Lectin pathway; Pattern recognition molecule; Recombinant protein

Mesh:

Substances:

Year:  2015        PMID: 26021447      PMCID: PMC4560653          DOI: 10.1016/j.jim.2015.05.008

Source DB:  PubMed          Journal:  J Immunol Methods        ISSN: 0022-1759            Impact factor:   2.303


  24 in total

1.  Biochemical and biological characterization of a dodecameric CD4-Ig fusion protein: implications for therapeutic and vaccine strategies.

Authors:  James Arthos; Claudia Cicala; Tavis D Steenbeke; Tae-Wook Chun; Charles Dela Cruz; Douglas B Hanback; Prateeti Khazanie; Daniel Nam; Peter Schuck; Sara M Selig; Donald Van Ryk; Margery A Chaikin; Anthony S Fauci
Journal:  J Biol Chem       Date:  2002-01-22       Impact factor: 5.157

2.  A soluble transforming growth factor-beta (TGF-beta ) type I receptor mimics TGF-beta responses.

Authors:  F Docagne; N Colloc'h; V Bougueret; M Page; J Paput; M Tripier; P Dutartre; E T MacKenzie; A Buisson; S Komesli; D Vivien
Journal:  J Biol Chem       Date:  2001-12-07       Impact factor: 5.157

3.  L-ficolin is a pattern recognition molecule specific for acetyl groups.

Authors:  Anders Krarup; Steffen Thiel; Annette Hansen; Teizo Fujita; Jens C Jensenius
Journal:  J Biol Chem       Date:  2004-08-25       Impact factor: 5.157

4.  Ficolin-2 recognizes DNA and participates in the clearance of dying host cells.

Authors:  Maria Lund Jensen; Christian Honoré; Tina Hummelshøj; Bjarke Endel Hansen; Hans Ole Madsen; Peter Garred
Journal:  Mol Immunol       Date:  2006-05-26       Impact factor: 4.407

5.  Calculation of protein extinction coefficients from amino acid sequence data.

Authors:  S C Gill; P H von Hippel
Journal:  Anal Biochem       Date:  1989-11-01       Impact factor: 3.365

6.  A novel human serum lectin with collagen- and fibrinogen-like domains that functions as an opsonin.

Authors:  M Matsushita; Y Endo; S Taira; Y Sato; T Fujita; N Ichikawa; M Nakata; T Mizuochi
Journal:  J Biol Chem       Date:  1996-02-02       Impact factor: 5.157

7.  Specific binding of L-ficolin and H-ficolin to apoptotic cells leads to complement activation.

Authors:  Mikio Kuraya; Zhenping Ming; Xianzhou Liu; Misao Matsushita; Teizo Fujita
Journal:  Immunobiology       Date:  2005       Impact factor: 3.144

8.  Cutting edge: complement-activating complex of ficolin and mannose-binding lectin-associated serine protease.

Authors:  M Matsushita; Y Endo; T Fujita
Journal:  J Immunol       Date:  2000-03-01       Impact factor: 5.422

9.  The disulfide bonding pattern in ficolin multimers.

Authors:  Tomoo Ohashi; Harold P Erickson
Journal:  J Biol Chem       Date:  2003-12-01       Impact factor: 5.157

10.  Dialysis-based bioreactor systems for the production of monoclonal antibodies--alternatives to ascites production in mice.

Authors:  Matthew P Bruce; Victoria Boyd; Christine Duch; John R White
Journal:  J Immunol Methods       Date:  2002-06-01       Impact factor: 2.303

View more
  3 in total

1.  Ficolin-2 inhibitors are present in sera after prolonged storage at -80 °C.

Authors:  Kimball Aaron Geno; Richard E Kennedy; Patricia Sawyer; Cynthia J Brown; Moon H Nahm
Journal:  PeerJ       Date:  2016-11-17       Impact factor: 2.984

2.  Ficolin-2 binds to serotype 35B pneumococcus as it does to serotypes 11A and 31, and these serotypes cause more infections in older adults than in children.

Authors:  K Aaron Geno; Brady L Spencer; Sejong Bae; Moon H Nahm
Journal:  PLoS One       Date:  2018-12-26       Impact factor: 3.240

3.  Ficolin-2 Lectin Complement Pathway Mediates Capsule-Specific Innate Immunity Against Invasive Pneumococcal Disease.

Authors:  Moon H Nahm; Jigui Yu; Juan J Calix; Feroze Ganaie
Journal:  Front Immunol       Date:  2022-03-28       Impact factor: 7.561

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.